Hikal Ltd
NSE:HIKAL

Watchlist Manager
Hikal Ltd Logo
Hikal Ltd
NSE:HIKAL
Watchlist
Price: 399.45 INR -1.38% Market Closed
Market Cap: 49.3B INR

Hikal Ltd
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Hikal Ltd
Net Income (Common) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
Hikal Ltd
NSE:HIKAL
Net Income (Common)
â‚ą745.7m
CAGR 3-Years
-27%
CAGR 5-Years
-4%
CAGR 10-Years
N/A
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Net Income (Common)
â‚ą53.7B
CAGR 3-Years
27%
CAGR 5-Years
26%
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Net Income (Common)
â‚ą49.9B
CAGR 3-Years
25%
CAGR 5-Years
25%
CAGR 10-Years
15%
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Net Income (Common)
â‚ą114.3B
CAGR 3-Years
21%
CAGR 5-Years
23%
CAGR 10-Years
8%
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Net Income (Common)
â‚ą18.6B
CAGR 3-Years
15%
CAGR 5-Years
27%
CAGR 10-Years
8%
M
Mankind Pharma Ltd
NSE:MANKIND
Net Income (Common)
â‚ą19.1B
CAGR 3-Years
15%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

Hikal Ltd
Glance View

Market Cap
49.3B INR
Industry
Pharmaceuticals

Hikal Ltd. engages in the manufacture of chemical intermediates, specialty chemicals, active pharma ingredients, and contract research activities. The company is headquartered in Navi Mumbai, Maharashtra. The Company’s operating segments include the crop protection and pharmaceuticals space. The Crop protection produce and trades in pesticides and herbicides. Its facilities are in Taloja, Mahad (Maharashtra), and Panoli (Gujarat). The Pharmaceuticals space produce and trades in active pharmaceuticals ingredients. Its facilities are in Jigani (Bengaluru) and Panoli (Gujarat). The Company’s products and services include gabapentin, thiabendazole, and diuron contract development and custom manufacturing of intermediates, application programming interface (APIs), and artificial intelligence (AI’s). The company offers solutions to route scouting, process development, analytical method development, technology development, process engineering, scale-up support, and small-scale synthesis.

HIKAL Intrinsic Value
356.36 INR
Overvaluation 11%
Intrinsic Value
Price

See Also

What is Hikal Ltd's Net Income (Common)?
Net Income (Common)
745.7m INR

Based on the financial report for Dec 31, 2024, Hikal Ltd's Net Income (Common) amounts to 745.7m INR.

What is Hikal Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
-4%

Over the last year, the Net Income (Common) growth was 4%. The average annual Net Income (Common) growth rates for Hikal Ltd have been -27% over the past three years , -4% over the past five years .

Back to Top